Fineotex Chemical's share price surged 8% after announcing a strategic US acquisition via its subsidiary, aiming to build a $200 million oilfield chemical business. Read key details and investor moves.
A new study reveals tattoo inks often contain harmful chemicals linked to skin cancer. Learn about the risks and crucial safety measures for tattoo enthusiasts.
Discover the hidden dangers of non-stick pans. Learn how PFOA, toxic fumes, and coating degradation can impact your health and get safer cooking alternatives.
CARE Ratings reaffirms Tata Chemicals' credit ratings, citing robust business model & Tata Group backing. Despite soda ash market challenges, TCL shows financial resilience. Read more.
New research reveals BPS chemical in thermal receipts can disrupt hormones, lower sperm count. Retail workers at highest risk. Learn how to protect yourself.
Speciality chemical makers supplying pharma CDMOs post 7% sales growth, outpacing non-pharma peers. Strong margins and global shifts fuel this resilient sector. Read more.
A 2025 study reveals 168 common industrial chemicals inhibit gut bacteria, challenging old safety assumptions. Learn the health risks and practical ways to protect your microbiome.
Sudeep Pharma shares surged 23% in stock market debut today, outperforming grey market expectations. The ₹895-crore IPO was subscribed 93.71 times. Read full analysis.
SMS Pharmaceuticals shares surged 17% after USFDA approved reformulated Ranitidine tablets. The approval marks the drug's return to US market after 5 years, boosting company's growth prospects.
Sudeep Pharma IPO allotment finalized today after massive 93.71x subscription. GMP at ₹87 signals 14.67% listing gain. Track your allotment status now!
India's pharmaceutical industry is transitioning toward innovative drugs, with multiple companies preparing obesity reduction launches. Discover how PHARMEXCIL is driving this competitive transformation.
Sudeep Pharma's ₹895 crore IPO witnessed massive demand, subscribed 94 times. QIB portion booked 213x. Shares may list at a 14% premium. Key details inside.
Indian government considers global tenders for patented weight-loss, cancer, and diabetes drugs to ensure patient access. Learn how this move benefits healthcare.
Indian-American billionaire Vivek Ramaswamy's fortune surges to $1.8B despite political setbacks. Discover how his pharma investments fueled this remarkable growth and his Ohio governor campaign.
Aurobindo Pharma's China facility currently faces $1M loss but aims for break-even by Q3-Q4 FY26. CFO outlines growth drivers including Pen-G ramp-up and biosimilar commercialization.
Karnataka Health Minister Dinesh Gundu Rao urges the pharma sector to adhere to regulations, highlighting critical public health and industry credibility issues.
India-US trade deal negotiations advance with $500 billion bilateral trade target by 2030. Experts reveal which Indian stocks could benefit most from tariff easing.
Eli Lilly makes pharmaceutical history as first company to achieve $1 trillion market capitalization after shares rose 1.7% on November 21, 2025. Learn what this means for investors.
A smallcap pharma stock listed on NSE defied market trends with a 10% surge on November 21, 2024. Discover the driving factors behind this remarkable performance.
Balaxi Pharmaceuticals shares surged 10% to ₹39.5 in intraday trade Friday, defying market weakness. However, the stock remains down 47.42% YTD with retail investors facing significant wealth erosion.
Navin Fluorine International rallies 80% in 2025 as CDMO revenues double, Darolutamide orders ramp up, and new capacity boosts FY26 outlook. Strong margin expansion fuels investor optimism.
Tragic boiler explosion at pharmaceutical factory in Pakistan's Punjab province claims 15 lives, leaves dozens injured. Emergency response underway.
OPPI Annual Summit 2025 highlights strategic partnerships accelerating India's pharmaceutical transformation. Discover key insights from industry leaders.
Sudeep Pharma's ₹895 crore IPO opens with ₹563-593 price band. Grey market shows ₹130 premium. Analysts recommend long-term investment for 2-5 years horizon.
Sudeep Pharma's ₹895 crore IPO opens today. Price band ₹563-593 per share. Learn about company details, investment minimums & global presence. Subscribe now!
India strengthens ties with Seychelles by delivering 3.5 tonnes of essential medicines. This humanitarian gesture showcases India's commitment to global health partnerships.
Reliance Industries shares surged nearly 2% to hit a four-month high of ₹1,542 as analysts maintained bullish stance on refining strength and new energy ventures. Discover investment insights.
Sudeep Pharma's ₹95 crore IPO opens November 21 with strong grey market premium. Learn price band, dates, financials & investment details for this pharma ingredients maker.
Forbes India honors Innocule in DGEMS 2025 for revolutionizing industrial materials. Discover how this innovation impacts India's manufacturing landscape.
Sudeep Pharma's ₹895 crore IPO opens November 21-25. Price band ₹563-593 per share. Company manufactures pharmaceutical excipients and speciality ingredients.